- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02216162
PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program (PROACTIVE)
PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program Including a Regular Physical Training, a Medical and Nutritional Follow-up, on Adjuvant Hormonal Treatment Compliance in Breast Cancer Patients Over 70 Years.
PROACTIVE randomized study to evaluate the impact of a multidimensional geriatric intervention on treatment compliance, measured regularly by blood dosing of drug metabolites.
Patients in the intervention group will be proposed:
- A regular geriatric follow up including an attentive screening of joint symptoms and functionality,
- An adapted treatment of join pain,
- Weekly sessions of adapted physical activity (Taï Chi),
- And a systematic correction of vitamin D deficits.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Lyon, Frankrig
- Claire Falandry
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age ≥ 70 years old
- Non metastatic breast cancer, with or without node metastases
- Hormone Receptor (HR) positive breast cancer patients
- Women with breast adenocarcinoma, confirmed by a pathologist and who underwent surgery or radiotherapy
- Introduce an hormonal therapy during 5 years
- Life expectancy > 6 months (at the discretion of the investigator)
- Covered by a Health System where applicable, and/or in compliance with the recommendations of the national laws in force relating to biomedical research
- Patient must be available for follow-up
- Having given written informed consent prior to any procedure related to the study
Exclusion Criteria:
- No other primary malignant tumor < 5-years old except cured in situ cancer of the cervix, in situ urothelial cancer, or basocellular cancer
- Patient with an experimental treatment in the 30 days prior to the enrollment
- Evidence of metastatic disease
- Not under any administrative or legal supervision
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: A: Interventional adapted physical activity + enhanced geriatr
Geriatric (functionality, gait, nutrition) follow-up, biological tests, anti-aromatase agents blood dosing, clinical assessment.
Weekly Taï-Chi exercises.
|
Patients have 3-monthly geriatric follow-up with biological tests, anti-aromatase agents blood dosing and a clinical assessment (M3 to M9, M15 to M22 and M27 to M33). Musculoskeletal adverse events and quality of life level will be reported and analgesic treatment adapted. Patients will be proposed weekly Taï-Chi exercises to improve joint flexibility, muscular tonus and balance and reduce fall risk. A broader geriatric assessment including functionality, gait analysis and nutrition will be performed each year (M12, M24 and M36). |
Andet: Arm B: control
Clinical follow-up according to the Guidelines, annual geriatric and nutritional assessment
|
Usual clinical follow-up
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Compliance of an adjuvant hormonal therapy
Tidsramme: 3 years of follow up
|
Compliance rate is defined as the rate of blood samplings of anti-hormone metabolites in the therapeutic range, within the 7 blood samplings distributed in the 3 years of follow-up
|
3 years of follow up
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Intensity and duration of musculoskeletal adverse events
Tidsramme: 3 years of follow up
|
Musculoskeletal adverse events will be graded using NCI CTC version 4.0
|
3 years of follow up
|
Activities of daily living, functional walking capacity and changes in balance
Tidsramme: 3 years of follow up
|
3 years of follow up
|
|
Quality of life
Tidsramme: 3 years of follow up
|
Using the Functional Assessment of Cancer Therapy General (FACT-G7) questionnaire
|
3 years of follow up
|
Nutritional status
Tidsramme: 3 years of follow up
|
Using Mini Nutritional Assessment, weight, weight loss, albuminemia
|
3 years of follow up
|
Analgesics consumption
Tidsramme: 3 years of follow up
|
issued from the exhaustive list of documented concomitant medications
|
3 years of follow up
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Claire Falandry, MD-PhD, Hospices Civils de Lyon
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2012-777
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Brystkræft
-
Cairo UniversityIkke rekrutterer endnu
-
Abouqir General HospitalAlexandria UniversityRekrutteringBreast Udseende Rekonstruktion DisproportionEgypten
-
ETOP IBCSG Partners FoundationAfsluttetBreast Cancer Invasive NosItalien
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; Roche Farma, S.AAfsluttetBreast Cancer Invasive NosSpanien
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital og andre samarbejdspartnereAfsluttetDen kliniske anvendelsesvejledning af Conebeam Breast CTKina
-
Ontario Clinical Oncology Group (OCOG)Afsluttet
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional...UkendtBRCA1 mutation | Breast Cancer Invasive NosPolen
-
Aga Khan UniversityAfsluttetBrystkræft | Perforatorklap | Brysttumor | Oncoplasty | Breast-QPakistan
-
University Health Network, TorontoAfsluttetBreast Cancer Invasive Nos | Primær invasiv brystkræftCanada
-
KU LeuvenNovartisUkendtER Positive, HER2 Negative Breast Cancer NeoplasmaBelgien